Lapatinib and Circulating Tumor Cells in Breast Cancer
NCT00694252
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Breast Cancer
Interventions
DRUG:
Lapatinib
Sponsor
University Hospital of Crete